MACLINZA

Generic Name: Daclatasvir

Indication:
Maclinza is indicated for use with Sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.

Strength: 60 mg
Pack Size: 28’s
Dosage Form: Tablets
Categories: Pharmaceutical
Therapeutic Class: Anti-viral